Лип
12
2017
The CRISPR stock took a beating at the end of May. Here's why it recovered somewhat last month.
З ГЕОІНФОРМАТИКИ ТА СТАЛОГО РОЗВИТКУ
The CRISPR stock took a beating at the end of May. Here's why it recovered somewhat last month.